Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis

Annals of the Rheumatic Diseases
C PopaP Barerra

Abstract

Tumour necrosis factor (TNF) is known to increase the concentrations of interleukin (IL) 6 and C reactive protein (CRP) and to induce proatherogenic changes in the lipid profile and may increase the cardiovascular risk of patients with rheumatoid arthritis (RA) and other inflammatory disorders. To assess whether anti-TNF therapy modifies the cardiovascular risk profile in patients with RA. The lipoprotein spectrum and the inflammation markers CRP and IL6 were investigated in 33 patients with RA treated with human anti-TNF monoclonal antibodies (D2E7, adalimumab, Humira) and 13 patients with RA given placebo, before and after 2 weeks' treatment. In the anti-TNF treated group, the mean (SD) concentrations of HDL-cholesterol were significantly higher after 2 weeks' treatment (0.86 (0.30) mmol/l v 0.98 (0.33) mmol/l, p<0.01), whereas LDL and triglyceride levels were not significantly changed. Additionally, a significant decrease in CRP (86.1 (54.4) mg/l v 35.4 (35.0) mg/l, p<0.0001), and IL6 (88.3 (60.5) pg/ml v 42.3 (40.7) pg/ml, p<0.001) concentrations was seen in this group. No changes in lipid profile, IL6, or CRP levels were seen in the placebo group. TNF neutralisation with monoclonal anti-TNF antibodies increased HDL-cholest...Continue Reading

Citations

Mar 18, 2009·Inflammatory Bowel Diseases·Erika Parmentier-DecrucqLaurent Peyrin-Biroulet
Mar 24, 2010·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Yinghui ZhangXiang-Dong Wang
Sep 24, 2010·Zeitschrift für Rheumatologie·I H TarnerC Hamm
Apr 13, 2010·Clinical Rheumatology·Eduardo Nicolas PollonoMaria E Suarez-Almazor
Dec 4, 2012·Dermatology and Therapy·Bruce E StroberMelodie Young
Nov 17, 2001·International Immunopharmacology·K A Brown
Aug 26, 2006·Nature Clinical Practice. Rheumatology·Jon T GilesJoan M Bathon
May 8, 2009·Nature Reviews. Cardiology·Gayle E McKellarIain B McInnes
May 3, 2011·Nature Reviews. Drug Discovery·Israel F Charo, Rebecca Taub
Nov 11, 2009·Nature Reviews. Rheumatology·Zoltán SzekaneczPál Soltész
Apr 2, 2009·Nature Reviews. Rheumatology·Mariana J Kaplan
Apr 4, 2006·Current Opinion in Rheumatology·Mariana J Kaplan
Apr 19, 2011·Current Opinion in Cardiology·Holly JohnGeorge D Kitas
Sep 22, 2007·Current Opinion in Lipidology·Johan KuiperTheo J C van den Berkel
Feb 26, 2005·Annals of the Rheumatic Diseases·C PopaJ W M van der Meer
Feb 23, 2007·Annals of the Rheumatic Diseases·M J L PetersM T Nurmohamed
Mar 6, 2007·Arthritis Research & Therapy·Jean Frédéric BoyerArnaud Constantin
Jul 20, 2010·Arthritis Research & Therapy·Jeffrey R CurtisElizabeth Delzell
May 25, 2010·Medicinski pregled·Biljana Obradović-TomasevićRatko Tomasević
Aug 2, 2011·Clinical & Developmental Immunology·Karla R CastroJozélio F Carvalho
May 28, 2014·European Heart Journal·Paul M Ridker, Thomas F Lüscher
Sep 22, 2005·Current Rheumatology Reports·Inmaculada del Rincón, Agustín Escalante
Feb 15, 2008·The Journal of Dermatological Treatment·Alice B GottliebFrank Dann
Nov 3, 2011·International Journal of Food Sciences and Nutrition·Golaleh AsghariFereidoun Azizi
Apr 22, 2008·Expert Opinion on Pharmacotherapy·J Avouac, Y Allanore
May 17, 2013·Expert Opinion on Emerging Drugs·Jeremy P BermanRobert S Rosenson
Apr 28, 2006·Scandinavian Journal of Rheumatology·S Rantapää DahlqvistO Johnson
Jul 12, 2008·Expert Opinion on Investigational Drugs·Maureen McMahon, Ernest Brahn
Jun 15, 2011·Seminars in Arthritis and Rheumatism·Alper M van SijlMichael T Nurmohamed
Jun 1, 2010·Rheumatic Diseases Clinics of North America·Mariana J Kaplan
Feb 11, 2010·Clinical Biochemistry·Dina ShahinMaha Houssen
Jun 19, 2009·Journal of the American Academy of Dermatology·Bruce StroberMelodie Young

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.